BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND DDX5, HLR1, 1655, ENSG00000108654, P17844, DKFZp686J01190, p68, G17P1, HUMP68
34 results:

  • 1. Disclosing Potential Therapeutic Targets Associated With Osimertinib Resistance in the Non-small Cell lung cancer Cell Line H1975.
    Tong X; Zhang R; Sun R; Yang W; Sun J; Chen J; Li F
    Anticancer Res; 2023 Dec; 43(12):5459-5474. PubMed ID: 38030186
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Molecular Insights into the Recruiting Between UCP2 and ddx5/UBAP2L in the Metabolic Plasticity of Non-Small-Cell lung cancer.
    Yang Z; Li G; Zhao Y; Zhang L; Yuan X; Meng L; Liu H; Han Y; Jia L; Zhang S
    J Chem Inf Model; 2021 Aug; 61(8):3978-3987. PubMed ID: 34308648
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Planning target volume density impact on treatment planning for lung stereotactic body radiation therapy.
    Savanović M; Jaroš D; Foulquier JN
    Acta Oncol; 2021 Oct; 60(10):1296-1300. PubMed ID: 34259116
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Silencing of Long Non-Coding RNA FGD5-AS1 Inhibits the Progression of Non-Small Cell lung cancer by Regulating the miR-493-5p/ddx5 Axis.
    Cui F; Luo P; Bai Y; Meng J
    Technol Cancer Res Treat; 2021; 20():1533033821990007. PubMed ID: 33550957
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A gene expression-based single sample predictor of lung adenocarcinoma molecular subtype and prognosis.
    Liljedahl H; Karlsson A; Oskarsdottir GN; Salomonsson A; Brunnström H; Erlingsdottir G; Jönsson M; Isaksson S; Arbajian E; Ortiz-Villalón C; Hussein A; Bergman B; Vikström A; Monsef N; Branden E; Koyi H; de Petris L; Patthey A; Behndig AF; Johansson M; Planck M; Staaf J
    Int J Cancer; 2021 Jan; 148(1):238-251. PubMed ID: 32745259
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The RNA helicase ddx5 supports mitochondrial function in small cell lung cancer.
    Xing Z; Russon MP; Utturkar SM; Tran EJ
    J Biol Chem; 2020 Jul; 295(27):8988-8998. PubMed ID: 32376686
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Analysis of early respiratory-related mortality after radiation therapy of non-small-cell lung cancer: feasibility of automatic data extraction for dose-response studies.
    Stervik L; Pettersson N; Scherman J; Behrens CF; Ceberg C; Engelholm S; Gunnarsson K; Hallqvist A; Nyman J; Persson GF; Pøhl M; Wahlstedt I; Vogelius IR; Bäck A
    Acta Oncol; 2020 Jun; 59(6):628-635. PubMed ID: 32202189
    [No Abstract]    [Full Text] [Related]  

  • 8. Characteristics and Outcomes of Patients With Metastatic KRAS-Mutant lung Adenocarcinomas: The lung cancer Mutation Consortium Experience.
    El Osta B; Behera M; Kim S; Berry LD; Sica G; Pillai RN; Owonikoko TK; Kris MG; Johnson BE; Kwiatkowski DJ; Sholl LM; Aisner DL; Bunn PA; Khuri FR; Ramalingam SS
    J Thorac Oncol; 2019 May; 14(5):876-889. PubMed ID: 30735816
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. MiR-431 suppresses proliferation and metastasis of lung cancer via down-regulating ddx5.
    Xu CM; Chen LX; Gao F; Zhu MF; Dai Y; Xu Y; Qian WX
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):699-707. PubMed ID: 30720177
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Video-assisted thoracoscopic surgery for lung cancer after induction therapy.
    Matsuoka K; Yamada T; Matsuoka T; Nagai S; Ueda M; Miyamoto Y
    Asian Cardiovasc Thorac Ann; 2018 Oct; 26(8):608-614. PubMed ID: 30249109
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. miRomics and Proteomics Reveal a miR-296-3p/PRKCA/FAK/Ras/c-Myc Feedback Loop Modulated by HDGF/ddx5/β-catenin Complex in lung Adenocarcinoma.
    Fu Q; Song X; Liu Z; Deng X; Luo R; Ge C; Li R; Li Z; Zhao M; Chen Y; Lin X; Zhang Q; Fang W
    Clin Cancer Res; 2017 Oct; 23(20):6336-6350. PubMed ID: 28751441
    [No Abstract]    [Full Text] [Related]  

  • 12. Genetic variations in cancer-related significantly mutated genes and lung cancer susceptibility.
    Zhang Y; Zhang L; Li R; Chang DW; Ye Y; Minna JD; Roth JA; Han B; Wu X
    Ann Oncol; 2017 Jul; 28(7):1625-1630. PubMed ID: 28383694
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Dynamic proteomics reveals bimodal protein dynamics of cancer cells in response to HSP90 inhibitor.
    Zimmer A; Amar-Farkash S; Danon T; Alon U
    BMC Syst Biol; 2017 Mar; 11(1):33. PubMed ID: 28270142
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The DEAD box protein p68: a novel coactivator of Stat3 in mediating oncogenesis.
    Sarkar M; Khare V; Ghosh MK
    Oncogene; 2017 Jun; 36(22):3080-3093. PubMed ID: 27941883
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. LMTK3 escapes tumour suppressor miRNAs via sequestration of ddx5.
    Jacob J; Favicchio R; Karimian N; Mehrabi M; Harding V; Castellano L; Stebbing J; Giamas G
    Cancer Lett; 2016 Mar; 372(1):137-46. PubMed ID: 26739063
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. A genome landscape of SRSF3-regulated splicing events and gene expression in human osteosarcoma U2OS cells.
    Ajiro M; Jia R; Yang Y; Zhu J; Zheng ZM
    Nucleic Acids Res; 2016 Feb; 44(4):1854-70. PubMed ID: 26704980
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. ddx5 promotes proliferation and tumorigenesis of non-small-cell lung cancer cells by activating β-catenin signaling pathway.
    Wang Z; Luo Z; Zhou L; Li X; Jiang T; Fu E
    Cancer Sci; 2015 Oct; 106(10):1303-12. PubMed ID: 26212035
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The DEAD box protein p68: a crucial regulator of AKT/FOXO3a signaling axis in oncogenesis.
    Sarkar M; Khare V; Guturi KK; Das N; Ghosh MK
    Oncogene; 2015 Nov; 34(47):5843-56. PubMed ID: 25745998
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Dose-intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: a randomized phase II study.
    Ishida T; Jo T; Takemoto S; Suzushima H; Uozumi K; Yamamoto K; Uike N; Saburi Y; Nosaka K; Utsunomiya A; Tobinai K; Fujiwara H; Ishitsuka K; Yoshida S; Taira N; Moriuchi Y; Imada K; Miyamoto T; Akinaga S; Tomonaga M; Ueda R
    Br J Haematol; 2015 Jun; 169(5):672-82. PubMed ID: 25733162
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Nuclear death receptor TRAIL-R2 inhibits maturation of let-7 and promotes proliferation of pancreatic and other tumor cells.
    Haselmann V; Kurz A; Bertsch U; Hübner S; Olempska-Müller M; Fritsch J; Häsler R; Pickl A; Fritsche H; Annewanter F; Engler C; Fleig B; Bernt A; Röder C; Schmidt H; Gelhaus C; Hauser C; Egberts JH; Heneweer C; Rohde AM; Böger C; Knippschild U; Röcken C; Adam D; Walczak H; Schütze S; Janssen O; Wulczyn FG; Wajant H; Kalthoff H; Trauzold A
    Gastroenterology; 2014 Jan; 146(1):278-90. PubMed ID: 24120475
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.